Objectives: The emphasis on integrated care implies new incentives that promote coordination between levels of care. Considering a population as a whole, the resource allocation system has to adapt to this environment. This research is aimed to design a model that allows for Results: The hybrid model reimburses integrated care organizations avoiding excessive risk transfer and maximizing incentives for efficiency in the provision. At the same time, it eliminates incentives for risk selection for a specific set of high risk individuals through the use of concurrent reimbursement in order to assure a proper classification of patients.
Introduction
The design of the incentives in health care represents a continuous challenge. Beyond payment for services, improving resource allocation for populations is increasingly a new requirement for health care coordination. In order to avoid fragmentation, integrated care organizations have been created and capitation arrangements are crucial in this environment. As a consequence, researchers and health policy-makers are devoting efforts to develop and implement riskadjustment systems for capitation. Prospective Risk Adjustment using capitation payments is the approach that is being used for HMO in the United States Medicare system and a number of other countries as Belgium, the Netherlands, Germany, Switzerland, and Israel [1] [2] [3] [4] [5] [6] [7] ; through the use of different information sets, as demographic information or diagnosis information. The existence of asymmetric information in the predictability of total health expenditures between single payers (as Medicare) and insurers with prospective risk adjustment also produces incentives for risk selection by attracting profitable insured and avoiding the unprofitable ones [8, 9] In a context of publicly funded health insurance, the transfer of financial risk to public integrated care organizations is vanishing and they may allow inefficiency. Furthermore, because access to health care is guaranteed for everyone, risk selection cannot consist of avoiding high risk patients (those for which the integrated care organization expects losses) as in a private context, but benefit selection may apply in a subliminal way. Hence, the most important problem under a National Health System is to provide incentives for efficiency in the purchasing and provision and in order to do that, it is also necessary to avoid any potential incentive for risk selection.
Any Risk Adjustment tool allows also the use of ex post diagnosis information (concurrent risk adjustment) or ex post information on costs in the payment formula (risk sharing), as shown in Van Barneveld et al. (1997) [10] or [11] . The consequence is that it reduces the financial risk assumed by health providers, with the positive result of a decrease in the incentives for risk selection, but also the negative result of a decrease in the incentives for efficiency. The tradeoff between efficiency and risk selection can be articulated through a mixed payment system for total health expenditures started to be explored in the literature in the last decades [12, 13] . In the last years, a mixed or hybrid risk adjustment formula with both prospective and concurrent information with the aim of maximizing incentives for efficiency while minimizing incentives for risk selection has been proposed by Luft and Dudley (2004) [14] and Dudley et al. (2003) [15] for total health expenditures. The same methodology has also been applied for pharmaceutical expenditures [16] .
The predictability of health expenditures is therefore a key issue for health policy makers given that the lower is the difference in the information between single payers and insurers or integrated care organizations, the lower incentives for risk selection and the higher incentives for efficiency through the use of risk adjustment [17] . Different studies have shown how the predictive power of both total health care expenditures [18] [19] [20] and pharmaceutical expenditures [21] [22] [23] is hugely improved through the use of diagnosis information under different systems.
Also, it is a recognized fact that a significant proportion of health care expenditures is concentrated in a small percentage of the population [24] . Hence, it becomes crucial to understand the relationship between morbidity and health expenditures and its variation, in order to allocate health resources in a proper and efficient way at a population level.
The analysis of total health expenditures comprehends the provision of health services in all primary care, hospital care, and specialist visits. A proportion of total costs consist of pharmaceutical expenditures, whose variation has been studied in different studies [25, 26] .
Furthermore, incentives in the provision of total health services have also been analyzed in the literature [9] . Different risk adjustment strategies have been studied in the literature, from the conventional (using a linear regression approach with the available information to predict costs) to the optimal risk adjustment [27, 28] . However, health policy makers have until now only used the linear regression specification in the conventional risk adjustment strategies, and in the literature [23] is shown how for drug expenditures, the use of other specifications as "parametric" or "flexibleparametric" models obtain very similar predictions than the simple linear regression model, which is simpler to interpret.
There are different information systems that have been developed to group patients by morbidity characteristics. Among others, the three most widely known are the Adjusted Clinical Groups (ACG) system developed at Johns Hopkins University [19] , the Diagnostic Cost Group (DCG) family of models developed at Boston University [1] , and the Clinical Risk Groups models [20, 29] . A recent comparison of the different information systems has been provided by the Society of Actuaries (2007) [30] .
In this paper we use individual data and analyze the relationship between total health expenditures and morbidity grouped with the CRG classification system for the population belonging to an integrated healthcare organization covered by the public health system in Catalonia, in the context of the Spanish publicly funded health system. The hybrid risk adjustment model is able to identify the expected and observed resources of the organization.
Data Sources
We use individual data on health expenditures and morbidity from an integrated healthcare organization, Serveis Sanitaris Integrats Baix Empordà (SSIBE), in Catalonia. The organization provides publicly funded health services (hospital care, primary care, and long-term care) to the population in the county of Baix Empordà. The health providers included in the analysis are the Palamós Hospital, with 100 beds for acute patients and 50 for skilled nursing care, and four out of the five Primary Care Centers in the county (Palamós, Torroella, la Bisbal, and Palafrugell).
The fifth Primary Care Center (Sant Feliu de Guixols) was excluded for incomplete data.
Although most of the health care provision to citizens in that county is registered, they also may receive health services outside the organization. Data on health provision and costs from outside the organization were not available and are omitted from our analysis.
The information collected at SSIBE integrates both clinical activities and costs. Thus, it consists of a unique identification patient file for all encounters including primary care, specialized care, and inpatient services, and a decentralized activity file codified in ICD-9-CM by clinicians and Among the possible grouping systems to apply risk adjustment strategies, we use in this article the Clinical Risk Groups (CRGs) (version 1.2B). It is characterized by classifying individuals in mutually exclusive categories while preserving clinical significance, and taking into account comorbidities and severity levels [20] . From the three different models provided by the CRG software, we use the concurrent model.
For each patient we get a unique CRG as well as its corresponding aggregation in ACRG1, ACRG2 and ACRG3. In this paper we describe the population through the highest level of aggregation (ACRG3) and for the estimations we use the second level of aggregation ACRG2 for the classification of patients in morbidity groups. This level of aggregation originally has 176 mutually exclusive categories. However we slightly modify those into 82 mutually exclusive categories fully maintaining its clinical significance by joining patients belonging to different CRGs of the same category but with different levels of severity, in order to avoid over fitting in our estimation because of a very low number of patients in some groups.
The total health expenditures information utilized incorporates residents as well as other persons that received services from SSIBE. Also it includes resident people with charge to international agreements or people whom they have provisional authentication codes. As a consequence, we are unable to completely allocate all health care expenditures since a small proportion stems from citizens not belonging to the resident's file. Table 1 
Estimation Methods
In this paper we estimate prospective, concurrent, and hybrid risk adjustment models using different information sets (demographic or health status information provided by the CRG categories) in order to predict total health expenditures in the subsequent year. Our objective is to examine the predictive power of each model, how well they explain future cost, and provide implications in terms of the application of a hybrid payment formula in the incentives of efficiency and risk selection in the health provision within a National Health System. The basic model is provided by:
The dependent variable, health expenditures in year t for individual i, is explained by some independent variables or risk adjusters (individual demographic characteristics and health status information). Demographic information is provided by twelve age-gender cells.
Prospective risk adjustment models predict total actual health expenditures with information on demographic characteristics and clinical status condition in year t-1. Differently, concurrent risk adjustment models predict total actual health expenditures using demographic and actual information on clinical status. Hybrid risk adjustment models combine both prospective and concurrent models. Pure prospective models promote incentives for efficiency but they are unable to avoid risk selection. Differently, the use of concurrent reimbursement models, as those based on actual information on cost (risk sharing) or health status (concurrent risk adjustment), presents lower incentives for risk selection because payment is associated to actual information, but incentives for efficiency are also reduced. The same specifications for the model have been used only for pharmaceutical expenditures [16] . However, in this article we include the policy analysis for total health expenditures.
The only use of diagnosis-based risk adjustment models does not solve the problem of risk selection because they do not capture within-condition variation even with concurrent information. Hence, following the idea in Newhouse (1996) [8] we propose the use of a hybrid risk adjustment model with information on health conditions different to the classification system used in the risk adjustment model, trying to rescue the positive properties of both prospective and concurrent formulae within the tradeoff between efficiency and risk selection: the hybrid model promotes incentives for efficiency as in the prospective model for most of the population, while it reduces incentives for risk selection for those patients suffering specific health conditions. The reimbursement associated to the second type of patients under the hybrid systems is set as a concurrent payment.
We utilize the set of 100 verifiable, expensive, predictive conditions (VEP100) already used and presented in the literature [15] in order to divide the population into two parts (one for the prospective payment and the other for the concurrent payment) and compare results.
It is key to understand the appropriateness of the use of those VEP conditions. First, it is needed that the conditions are verifiable -which means that belonging to those categories is based on objective clinical measures-because we avoid the incentives in the provider of classifying to this set of patients simply to any patient producing expected losses. Second, being expensive and predictive conditions we are selecting for belonging to the group of concurrent payment to the type of patients that might be at risk of suffering risk selection or excessive risk transfer to the organization.
Provided the importance of the division of the population between the two groups, we also include a sensitivity analysis through the use of a different division in order to better understand the scope of the VEP conditions in health policy making: the division between patients suffering or not at least one condition in the set of the 50 most expensive conditions within the VEP100 conditions, which we name VEP50.
We are using for our sample the set of VEP100 conditions presented in the literature for a U.S.
sample. Therefore, it is needed to present an analysis validating the use of the same division of patients in concurrent and prospective populations within the hybrid model, because the characteristics of both samples might be different.
The predictive power of risk adjustment models depends on the within-group variation in expected expenditures. Thus, we check for the distribution of the appearance of VEP100 conditions under the CRG classification system and the same type of data with respect to the division of the population between those patients suffering or not at least one of the VEP50 conditions.
We provide a second analysis justifying the use of VEP conditions. We compare the relative cost weights of the set of patients with and without VEP100 conditions and a sensitivity analysis for the division using VEP50 conditions is also presented.
In order to analyze the predictive power of the different models we use the R 2 and the predictive ratio. Hybrid models take into account the two sub-samples with concurrent information for patients with at least one VEP100 condition and prospective information for patients with no VEP100 condition. Therefore, in order to calculate the R 2 for hybrid models, we use the following methodology [15] : we first calculate the total error sum of squares for the combined populations (concurrent and prospective) as the error sum of squares for the concurrent population plus the error sum of squares from the prospective population. At the same time, the corrected total sum of squares is calculated as the sum of squares adjusted for the mean of the overall population. Finally, the R 2 is defined as one minus the ratio of the error sum of squares to the corrected total sum of squares. Table 2 shows how in relative terms, 95% of healthy patients do not suffer any VEP100 When dividing population into two parts depending on the presence of at least one VEP100 condition, the R 2 is of 0.1685 (model 5c) in the prospective models for patients without those conditions increases but is lower to that of the concurrent model for the whole population (0.2473 in model 2c). This means that the predictability of the cost for healthier patients (85.93% of the population without VEP100 conditions) is lower than that of patients with higher level of severity (14.07% of the population with at least one VEP100 condition). In other words, the asymmetry of information regarding clinical conditions of individuals is especially important for patients with higher level of severity which evidences the existence of incentives for risk selection or excessive risk transfer. The interpretation of this result is that the free variation in total health expenditures is specially concentrated in patients suffering one VEP100 conditions because most of them still belong to relatively healthy CRG categories. Concurrent models applied only for patients with at least one VEP100 condition improve the predictive power of total health expenditures (comparing models 2 with models 4) with an R 2 of 0.2211 using only CRG information (model 4a), of 0.2300 using also demographic information (model 4b), and of 0.4614 when using also information on the presence of VEP100 conditions (model 4c).
Results
We obtain an R 2 for hybrid models of 0.2006 (model 6a) using only CRG information, which is very similar to the predictive power of the usual prospective model using the same information (model 2a presented a R 2 of 0.1995), and adding demographic information also present similar results in both purely prospective and hybrid models (R 2 of 0.2187 in model 2b and of 0.2140 in model 6b). Therefore, having the same incentives for efficiency for most of the population (85.93%), focused on those individuals without VEP100 conditions, we are eliminating the incentives for risk selection in the population at risk of suffering such a strategy (14.07%).
Adding information regarding the VEP conditions improves the predictive power presenting an R 2 of 0.3571 (model 6c) higher than in the purely prospective model (model 2c). The sensitivity analysis provides the same exercise on the predictive models but dividing population between those with or without at least one of the VEP50 conditions. Thus, models 7 to 9 are analogous to models 4 to 6 in table 5. In this case, the proportion of the population for which efficiency incentives are maximized is of 90.99%, while the incentives for risk selection are eliminated for the 9.01% of the population suffering at least one of the VEP50 conditions. Results in the sensitivity analysis confirm those already obtained.
It is important to note as a limit for comparison with other results presented in the literature that our R 2 are probably higher than should be expected in other national samples. The reason is that all of the providers are from a narrow geographic area, and hence total health expenditures and practice style variations are reduced compared to other greater national samples. Besides, the number of parameters in the estimations (different models c) explains the high R 2 obtained.
They are shown however with the aim of showing the validity of the hybrid risk adjustment tool with a higher level of information more than pretending to obtain a higher predictive power. conditions. Hybrid models improve the predictive ratio for patients in most of CRG categories, but especially when patients are ordered by deciles of drug expenditures or by presence of VEP100 or VEP50 conditions.
Conclusions
Mixed risk adjustment models for capitation payment have been considered by the literature as the appropriate approach for allocating resources. However implementation of such models represents a challenge because of information available and other constraints. A better prediction of health care expenditures for integrated care organizations allows to control for excessive risk transfer. Although in a private insurance market the application of risk adjustment supposes the transfer of financial risk, this transfer is not achieved (at least not complete) under a publicly funded systems. A transition to reimbursement based on risk adjustment strategies in publicly funded systems is therefore desirable in order to promote incentives for efficiency.
A mixed payment using the hybrid risk adjustment model promotes incentives for efficiency in the provision for a high proportion of the population through the prospective payment, but it also reduces excessive risk transfer to integrated care organizations through a concurrent payment based on actual information either on diagnosis (concurrent risk adjustment) or cost (risk sharing) for a determined set of patients. A key stage in the application of this hybrid model is the division between the set of patients with a prospective and a concurrent payment. In this paper we follow a methodology previously used in the literature based on the presence of 100 verifiable, expensive and predictive conditions (VEP100) in order to be able to compare results.
However, because our sample is different, we provide a check for the validity of the methodology. Furthermore, because it is not shown in the literature an optimal way of dividing population between the two groups with concurrent and prospective reimbursement methods,
we provide a sensitivity analysis using only a subset of 50 conditions (VEP50) obtaining positive results.
The hybrid model has been shown to obtain similar or higher predictive power than purely prospective or concurrent risk adjustment models through the R 2 , but the predictive ratio analysis shows how it is especially powerful at adjusting total health care expenditures for the set of patients at risk of suffering risk selection.
The application of risk adjustment strategies in the context of a publicly funded health system should in the future consider the effects of incentives in the standard setting of qualities in the provision or times of health attendance. 
